Pharma-Bio Serv Inc
OTC:PBSV
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Pharma-Bio Serv Inc
OTC:PBSV
|
PR |
|
Arcus Development Group Inc
F:AJR
|
CA |
|
Los Cerros Ltd
ASX:LCL
|
AU |
|
S
|
Seosan Co Ltd
KOSDAQ:079650
|
KR |
|
T
|
TSKY Co Ltd
TPEX:6784
|
TW |
|
T
|
Terang Dunia Internusa PT
IDX:UNTD
|
ID |
|
K
|
KNK Holdings Ltd
HKEX:8039
|
HK |
|
T
|
Tu Liem Urban Development JSC
VN:NTL
|
VN |
|
M
|
Monex Group Inc
OTC:MNXBF
|
JP |
|
C
|
Cornerstone Bancorp Inc
OTC:CNBP
|
US |
|
Nutex Health Inc
NASDAQ:NUTX
|
US |
|
ENB Financial Corp
OTC:ENBP
|
US |
|
T
|
The Codi Co Ltd
KOSDAQ:224060
|
KR |
|
T
|
ToolGen Inc
KOSDAQ:199800
|
KR |
|
A
|
ACI Infocom Ltd
BSE:517356
|
IN |
|
Sirohia & Sons Ltd
BSE:538667
|
IN |
Wall St Price Targets
PBSV Price Targets Summary
Pharma-Bio Serv Inc
According to Wall Street analysts, the average 1-year price target for
PBSV is 1.58 USD with a low forecast of 1.57 USD and a high forecast of 1.63 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PBSV's stock price target?
Price Target
1.58
USD
According to Wall Street analysts, the average 1-year price target for
PBSV is 1.58 USD with a low forecast of 1.57 USD and a high forecast of 1.63 USD.
What is the Revenue forecast for Pharma-Bio Serv Inc?
Projected CAGR
21%
Over the last 13 years, the compound annual growth rate for Revenue has been -9%. The projected CAGR for the next 2 years is 21%.